These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
540 related articles for article (PubMed ID: 26104043)
1. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function. Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043 [TBL] [Abstract][Full Text] [Related]
2. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis. Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772 [TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic Acid Attenuated Experimental Chronic Colitis in Interleukin 10-Deficient Mice by Enhancing Autophagy Through Inhibition of the mTOR Pathway. Zhao J; Dong JN; Wang HG; Zhao M; Sun J; Zhu WM; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):824-829. PubMed ID: 26407598 [TBL] [Abstract][Full Text] [Related]
4. Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice. Wang H; Shi P; Zuo L; Dong J; Zhao J; Liu Q; Zhu W J Crohns Colitis; 2016 Sep; 10(9):1076-86. PubMed ID: 26944415 [TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid (DHA) alleviates inflammation and damage induced by experimental colitis. Ariturk LA; Cilingir S; Kolgazi M; Elmas M; Arbak S; Yapislar H Eur J Nutr; 2024 Oct; 63(7):2801-2813. PubMed ID: 39105785 [TBL] [Abstract][Full Text] [Related]
6. Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function. Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J Int Immunopharmacol; 2015 Dec; 29(2):423-432. PubMed ID: 26603637 [TBL] [Abstract][Full Text] [Related]
7. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725 [TBL] [Abstract][Full Text] [Related]
8. SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice. Dong J; Wang H; Zhao J; Sun J; Zhang T; Zuo L; Zhu W; Gong J; Li Y; Gu L; Li J Immunol Res; 2015 Mar; 61(3):303-11. PubMed ID: 25588868 [TBL] [Abstract][Full Text] [Related]
9. GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice. Zhao J; Wang H; Shi P; Wang W; Sun Y Oncotarget; 2017 Jan; 8(5):8397-8405. PubMed ID: 28039475 [TBL] [Abstract][Full Text] [Related]
10. Glial-derived neurotrophic factor regulates intestinal epithelial barrier function and inflammation and is therapeutic for murine colitis. Zhang DK; He FQ; Li TK; Pang XH; Cui DJ; Xie Q; Huang XL; Gan HT J Pathol; 2010 Oct; 222(2):213-22. PubMed ID: 20632386 [TBL] [Abstract][Full Text] [Related]
11. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice. Chun J; Lee C; Hwang SW; Im JP; Kim JS Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474 [TBL] [Abstract][Full Text] [Related]
12. Hirsutenone reduces deterioration of tight junction proteins through EGFR/Akt and ERK1/2 pathway both converging to HO-1 induction. Seo GS; Jiang WY; Park PH; Sohn DH; Cheon JH; Lee SH Biochem Pharmacol; 2014 Jul; 90(2):115-25. PubMed ID: 24853984 [TBL] [Abstract][Full Text] [Related]
13. Ameliorative effect of Alnus japonica ethanol extract on colitis through the inhibition of inflammatory responses and attenuation of intestinal barrier disruption in vivo and in vitro. Chi JH; Kim YH; Sohn DH; Seo GS; Lee SH Biomed Pharmacother; 2018 Dec; 108():1767-1774. PubMed ID: 30372880 [TBL] [Abstract][Full Text] [Related]
14. Fructooligosaccharides exert intestinal anti-inflammatory activity in the CD4+ CD62L+ T cell transfer model of colitis in C57BL/6J mice. Capitán-Cañadas F; Ocón B; Aranda CJ; Anzola A; Suárez MD; Zarzuelo A; de Medina FS; Martínez-Augustin O Eur J Nutr; 2016 Jun; 55(4):1445-54. PubMed ID: 26154776 [TBL] [Abstract][Full Text] [Related]
15. Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions. Beguin P; Errachid A; Larondelle Y; Schneider YJ Food Funct; 2013 Jun; 4(6):923-31. PubMed ID: 23660640 [TBL] [Abstract][Full Text] [Related]
16. Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier. Bowie RV; Donatello S; Lyes C; Owens MB; Babina IS; Hudson L; Walsh SV; O'Donoghue DP; Amu S; Barry SP; Fallon PG; Hopkins AM Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G781-93. PubMed ID: 22241861 [TBL] [Abstract][Full Text] [Related]
17. Peiminine ameliorates Crohn's disease-like colitis by enhancing the function of the intestinal epithelial barrier through Nrf2/HO1 signal. Qiu Q; Geng Z; Wang L; Zuo L; Deng M; Zhang H; Yang Y; Wang Y; Zhao Z; Wen H; Wang Q; Wang Y; He X; Li J; Wang Y; Zhang X; Liu M; Song X Int Immunopharmacol; 2024 Jul; 136():112380. PubMed ID: 38850790 [TBL] [Abstract][Full Text] [Related]
18. Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling. Wang L; Song X; Zhou Y; Xia Y; Yang Z; Chen X; Shi R; Geng Z; Zhang X; Wang Y; Li J; Hu J; Zuo L Int Immunopharmacol; 2024 May; 133():112140. PubMed ID: 38669952 [TBL] [Abstract][Full Text] [Related]
19. Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression. Kuo WT; Shen L; Zuo L; Shashikanth N; Ong MLDM; Wu L; Zha J; Edelblum KL; Wang Y; Wang Y; Nilsen SP; Turner JR Gastroenterology; 2019 Nov; 157(5):1323-1337. PubMed ID: 31401143 [TBL] [Abstract][Full Text] [Related]
20. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice. Zhang H; Xue Y; Wang H; Huang Y; Du M; Yang Q; Zhu MJ World J Gastroenterol; 2014 Jul; 20(27):9106-15. PubMed ID: 25083083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]